TAF1 anticorps
-
- Antigène Voir toutes TAF1 Anticorps
- TAF1 (TAF1 RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 250kDa (TAF1))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TAF1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Réactivité croisée
- Humain, Souris, Rat
- Purification
- Affinity purification
- Immunogène
- Polyclonal antibody raised in rabbit against TAF1 using a KLH-conjugated synthetic peptide.
- Top Product
- Discover our top product TAF1 Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
IHC-P 1:200-400
IF() - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.15 g/L
- Buffer
- 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 and 0.01 % sodium azide.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- TAF1 (TAF1 RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 250kDa (TAF1))
- Autre désignation
- TAF1 (TAF1 Produits)
- Synonymes
- anticorps BG:DS00004.13, anticorps CG17603, anticorps Dmel\\CG17603, anticorps EfW1, anticorps SR3-5, anticorps TAF, anticorps TAF1, anticorps TAF200, anticorps TAF230, anticorps TAF250, anticorps TAF250/230, anticorps TAFII-250, anticorps TAFII250, anticorps TAF[II]250, anticorps TAF[[II]], anticorps TAF[[II]]230, anticorps TAF[[II]]250, anticorps TAF[[II]]250/230, anticorps TFIID, anticorps TFIID TAF250, anticorps Taf1p, anticorps Taf200, anticorps Taf230, anticorps Taf250, anticorps Taf[[II]]250, anticorps cel, anticorps cell, anticorps d230, anticorps dTAF230, anticorps dTAF250, anticorps dTAFII250, anticorps dTAF[[II]]230, anticorps dTAF[[II]]250, anticorps dmTAF1, anticorps dmTAF[[II]]230, anticorps l(3)84Ab, anticorps p230, anticorps 250kDa, anticorps AU015687, anticorps B430306D02Rik, anticorps Ccg-1, anticorps Ccg1, anticorps KAT4, anticorps N-TAF1, anticorps Taf2a, anticorps RGD1562050, anticorps BA2R, anticorps CCG1, anticorps CCGS, anticorps DYT3, anticorps DYT3/TAF1, anticorps NSCL2, anticorps OF, anticorps P250, anticorps TAF2A, anticorps XDP, anticorps TAF(II)250, anticorps p250, anticorps TBP-associated factor 1, anticorps TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa, anticorps transcription initiation factor TFIID subunit 1, anticorps transcription initiation factor TFIID, subunit TAF1, anticorps TATA-box binding protein associated factor 1, anticorps Taf1, anticorps TAF1, anticorps LOC5567420, anticorps CpipJ_CPIJ003658, anticorps TAF11.1, anticorps HAF1501, anticorps HAF1502, anticorps LOC100457071
- Sujet
-
Synonyms: TAFII250, p250, BA2R, CCG1, CCGS, TAF2A, KAT4, NSCL2, DYT3
Background: Largest component and core scaffold of the TFIID basal transcription factor complex (PubMed:25412659, PubMed:27007846). Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity (PubMed:25412659). Essential for progression of the G1 phase of the cell cycle (PubMed:11278496, PubMed:15053879, PubMed:2038334, PubMed:8450888, PubMed:8625415, PubMed:9660973, PubMed:9858607). Exhibits histone acetyltransferase activity towards histones H3 and H4 (PubMed:15870300).
- ID gène
- 6872
- UniProt
- P21675
-